Hovione
Hovione, established in 2015, is a Portugal-based pharmaceutical company specializing in the manufacturing of drug substances for off-patent and new drugs. It focuses on complex drug testing, molecule screening, and particle engineering to accelerate and enhance drug development, particularly in dermatology, ophthalmology, and respiratory fields. Hovione partners with pharmaceutical customers to complete clinical development, regulatory approval, and commercialization, aiming to make treatments faster and more affordable.
Top Stages
Past deals in Lisbon
CellmAbs
Seed Round in 2019
CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.
CellmAbs
Seed Round in 2019
CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.